Global /China /Healthcare /Drug Manufacturers - General /603235

JiangXi Tianxin Pharmaceutical Co., Ltd.

603235

• SSE: 603235 • Delayed

26.35CNY -0.1%

3.89 USD

As of 16 June 2026, JiangXi Tianxin Pharmaceutical Co., Ltd. has a market cap of $1.69B USD, ranking #7838 globally and #1985 in China. It ranks #651 in the Healthcare sector, and #250 in the Drug Manufacturers - General industry.

Global Rank

7838

Country Rank

1985

Sector Rank

651

Industry Rank

250

Key Stats

Market Cap

$1.69BUSD

11.47B CNY

Enterprise Value

$1.52BUSD

10.3B CNY

Revenue (TTM)

$346.32MUSD

2.35B CNY

EBITDA (TTM)

$129.41MUSD

875.78M CNY

Net Income (TTM)

$87.36MUSD

591.58M CNY

EBITDA Margin

37%

Profit Margin

25%

PE Ratio

19.5

PS Ratio

4.9

PB Ratio

2.3

EV/EBITDA

11.7

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Xiaobing Yua open_in_new

Employees

2,679

Founded

2004

Website

txpharm.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-0.1%	-0.4%	-1.2%	-2.3%	-2.1%	-2.3%	-0.9%	-10%	-47%

News

Markets

Exchange	Ticker	Price	Quotes
Shanghai Stock Exchange (SSE / SHA) MIC: XSHG PRIMARY	603235 江西天新药业股份有限公司 Class A ISIN: CNE100005Q89 Shares Out.: Shares Outstanding: 41.17M¹ Shares Float: 13.83M² TV: TradingView: SSE: 603235 SA: Stock Analysis: SHA: 603235 YF: Yahoo Finance: 603235.SS GF: Google Finance: SHA: 603235 BA: Barron's: 603235 MS: Morningstar: XSHG: 603235	26.35 CNY	TV: TradingView: SSE: 603235 SA: Stock Analysis: SHA: 603235 YF: Yahoo Finance: 603235.SS GF: Google Finance: SHA: 603235 BA: Barron's: 603235 MS: Morningstar: XSHG: 603235

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About JiangXi Tianxin Pharmaceutical Co., Ltd.

JiangXi Tianxin Pharmaceutical Co., Ltd. produces and sells vitamins in China. The company offers products of vitamin B6, vitamin B1, Vitamin D3, pyridoxine hydrochloride CD grade, thiamine nitrate DC grade, folic acid, biotin, ascorbyl palmitate, vitamin E 500, α-acetyl-γ-butyrolactone, and vitamin D3 for use as bulk pharmaceutical chemicals, API, food additives, and feed additives, as well as in other fields. JiangXi Tianxin Pharmaceutical Co., Ltd. was founded in 2004 and is based in Leping, China.

Similar Companies

Industry: Drug Manufacturers - General (China)

Name	Market Cap (USD) diff.	PE	Country
Jiangsu Hengrui Pharmaceuticals Co.,Ltd SSE: 600276	$53.89B 364.89B CNY 3K%	44.9	China
WuXi AppTec Co., Ltd. SSE: 603259	$49.67B 336.36B CNY 3K%	17.2	China
Hansoh Pharmaceutical Group Company Ltd. SHEK: 3692	$28.52B 223.48B HKD 2K%	35.7	China
Innovent Biologics, Inc. SHEK: 1801	$18.8B 147.32B HKD 1K%	162.3	China
Sichuan Biokin Pharmaceutical Co.,Ltd. SSE: 688506	$16.52B 111.89B CNY 876%	-	China
Akeso, Inc. SHEK: 9926	$16.01B 125.46B HKD 846%	-	China

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 45K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 32K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 21K%	97.4	United States
Roche Holding AG SIX: RO	$320.51B 256.25B CHF 19K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$288.14B 215.59B GBP 17K%	27.6	United Kingdom
Merck & Co., Inc. NYSE: MRK	$274.03B 16K%	15.1	United States

chevron_leftBack